The Journal of Headache and Pain

Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
Baron EP., Lucas P. and Hogue O. 

Migraine is first cause of disability in under 50s: will health politicians now take notice?
Steiner TJ., Stovner LJ., Vos T., Jensen R. and Katsarava Z.

Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study
Schwedt TJ, Alam A., Reed ML., Fanning KM., Munjal S. et al.

Medication-overuse headache: a widely recognized entity amidst ongoing debate
Vandenbussche N., Laterza D., Lisicki M., Lloyd J., Lupi C. et al.

The association between migraine and physical exercise
Amin FM., Aristeidou S., Baraldi C., Czapinska-Ciepiela EK., Ariadni DD. et al.

PACAP38 and PAC1 receptor blockade: a new target for headache?
Rubio-Beltrán E., Correnti E., Deen M., Kaam K., Kelderman T. et al.

Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
Ashina M., and Martelletti P.

Altered muscle activity during rest and during mental or physical activity is not a trait symptom of migraine - a neck muscle EMG study
Leudtke K., Mehnert J. and May A.

My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed
Martelletti P., Schwedt TJ., Lanteri-Minet M., Quintana R., Carboni V. et al.

Migraine and cluster headache – the common link
Vollesen AL., Benemei S., Cortese F., Labastida-Ramírez A., Marchese F. et al.

(Publication year 2018. Data collected February 2019. Source: Altmetric)

Interictal burden attributable to episodic headache: findings from the Eurolight project
Lampl C., Thomas H., Stovner LJ., Tassorelli C., Katsarava Z. et al. 

GBD 2015: migraine is the third cause of disability in under 50s
Steiner TJ., Stovner LJ. And Vos T.

Impact of migraine on fibromyalgia symptoms
Giamberardino MA., Affaitati G., Martelletti P., Tana C., Negro, A. et al.

Release of PACAP-38 in episodic cluster headache patients - an exploratory study
Tuka B., Szabó N., Tóth E., Kincses ZT., Párdutz Á. et al.

Calcitonin gene-related peptide and pain: a systematic review
Schou WS., Ashina S., Amin FM., Goadsby PJ. and Ashina M.

Altered kynurenine pathway metabolites in serum of chronic migraine patients
Curto M., Lionetto L., Negro A., Capi M., Fazio F. et al.

The burden of headache disorders in Nepal: estimates from a population-based survey
Manandhar K., Risal A., Linde M. and Steiner TJ.

Headache, depression and anxiety: associations in the Eurolight project
Lampl C., Thomas H., Tassorelli C., Katsarava Z., Miguel Laínez J. et al.

Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials
Morra ME., Elgebaly A., Elmaraezy A., Khalil, AM., Altibi AMA. et al.

Blocking CGRP in migraine patients - a review of pros and cons
Deen M., Correnti E., Kamm K., Kelderman T., Papetti L. et al.

Oxidative stress and DNA damage in patients with migraine
Geyik S., Altunisik E., Neyal AM. and Taysi S.

Altered serum levels of kynurenine metabolites in patients affected by cluster headache
Curto M., Lionetto L., Negro A., Capi M., Perugino F. et al.

European headache federation consensus on technical investigation for primary headache disorders
Mitsikostas DD., Ashina M., Craven A., Diener HC., Goadsby PJ. et al.

Cost-effectiveness analysis of non-invasive vagus nerve stimulation for the treatment of chronic cluster headache
Morris J., Straube A., Diener H-C., Ahmed F., Silver N. et al.

Clinically relevant behavioral endpoints in a recurrent nitroglycerin migraine model in rats
Sufka K., Staszko SM., Johnson AP., Davis ME., Davis RE. et al.

Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up
Grazzi L., Sansone E., Raggi A., D'Amico D., De Giorgio A. et al.

The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache
Pihut M., Ferendiuk E., Szewczyk M., Kasprzyk K. and Wieckiewicz M.

Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study
Grazzi L., Egeo G., Calhoun AH., McClure CK., Liebler E. et al.

Altered effective connectivity of posterior thalamus in migraine with cutaneous allodynia: a resting-state fMRI study with granger causality analysis
Wang T., Chen N., Zhan W., Liu J., Zhang J. et al.

The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis
Hou M., Xing H., Cai Y., Li B., Wang X. et al.

(Publication years 2016-2017). Data collected February 2019. Source: Web of Science)